Qube Research & Technologies (QRT)
BBNX

Qube Research & Technologies (QRT)’s Beta Bionics BBNX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$583K Buy
58,156
+40,778
+235% +$603K ﹤0.01% 2683
2025
Q4 		$530K Buy
+17,378
New +$464K ﹤0.01% 2783

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Qube Research & Technologies (QRT)'s BBNX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Beta Bionics (BBNX) stake by 235% in Q1 2026, buying an estimated $603K and bringing the position to 58,156 shares worth $583K. The position accounts for ﹤0.01% of the portfolio, ranked #2683.

Qube Research & Technologies (QRT) first reported a position in BBNX in Q4 2025 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 58,156 shares of Beta Bionics worth $583K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 40,778 Beta Bionics shares in Q1 2026, an estimated $603K.
  • Beta Bionics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2683 holding.
  • Qube Research & Technologies (QRT) first reported a position in Beta Bionics in Q4 2025 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.